A detailed history of Bellecapital International Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Bellecapital International Ltd. holds 68,378 shares of PFE stock, worth $1.9 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
68,378
Previous 46,123 48.25%
Holding current value
$1.9 Million
Previous $1.33 Million 42.95%
% of portfolio
0.44%
Previous 0.31%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $576,181 - $661,641
22,255 Added 48.25%
68,378 $1.9 Million
Q4 2023

Jan 22, 2024

BUY
$26.13 - $33.94 $352,519 - $457,884
13,491 Added 41.34%
46,123 $1.33 Million
Q3 2023

Oct 17, 2023

BUY
$32.09 - $37.51 $281,044 - $328,512
8,758 Added 36.68%
32,632 $1.08 Million
Q2 2023

Jul 07, 2023

BUY
$36.12 - $41.79 $42,549 - $49,228
1,178 Added 5.19%
23,874 $875,000
Q1 2023

Apr 25, 2023

BUY
$39.39 - $51.28 $199,983 - $260,348
5,077 Added 28.82%
22,696 $925,000
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $9,393 - $12,262
225 Added 1.29%
17,619 $903,000
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $23,105 - $28,205
528 Added 3.13%
17,394 $761,000
Q2 2022

Jul 27, 2022

SELL
$46.53 - $55.17 $24,567 - $29,129
-528 Reduced 3.04%
16,866 $884,000
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $44,331 - $54,932
969 Added 5.9%
17,394 $900,000
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $6,611 - $9,800
160 Added 0.98%
16,425 $970,000
Q2 2021

Jul 28, 2021

SELL
$35.91 - $40.68 $78,283 - $88,682
-2,180 Reduced 11.82%
16,265 $637,000
Q1 2021

Apr 13, 2021

SELL
$33.49 - $37.77 $45,378 - $51,178
-1,355 Reduced 6.84%
18,445 $668,000
Q4 2020

Jan 14, 2021

BUY
$33.47 - $42.56 $129,026 - $164,068
3,855 Added 24.18%
19,800 $729,000
Q3 2020

Oct 16, 2020

BUY
$31.75 - $37.25 $71,151 - $83,477
2,241 Added 16.35%
15,945 $585,000
Q2 2020

Jul 16, 2020

BUY
$30.12 - $36.54 $412,764 - $500,744
13,704 New
13,704 $448,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bellecapital International Ltd. Portfolio

Follow Bellecapital International Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.